Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Golimumab> ?p ?o }
- Golimumab abstract "Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.Golimumab was developed by Centocor and is approved in Canada and the United States as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Golimumab has been approved in 2013 for use in adults with moderately to severely active ulcerative colitis.In the same year, Johnson & Johnson, the parent company of Centocor, also received an approval from European Medicines Agency (EMEA) for the use of golimumab as a treatment for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Golimumab is marketed by Merck & Co, Inc. in Europe, pending final arbitration between J&J and Merck.".
- Golimumab atcPrefix "L04".
- Golimumab atcSuffix "AB06".
- Golimumab casNumber "476181-74-5".
- Golimumab fdaUniiCode "91X1KLU43E".
- Golimumab wikiPageExternalLink article.php?article_id=7069.
- Golimumab wikiPageID "9133439".
- Golimumab wikiPageLength "5195".
- Golimumab wikiPageOutDegree "20".
- Golimumab wikiPageRevisionID "704285382".
- Golimumab wikiPageWikiLink Ankylosing_spondylitis.
- Golimumab wikiPageWikiLink Category:Janssen_Biotech.
- Golimumab wikiPageWikiLink Category:Johnson_&_Johnson.
- Golimumab wikiPageWikiLink Category:TNF_inhibitors.
- Golimumab wikiPageWikiLink European_Medicines_Agency.
- Golimumab wikiPageWikiLink Human.
- Golimumab wikiPageWikiLink Immunosuppressive_drug.
- Golimumab wikiPageWikiLink Janssen_Biotech.
- Golimumab wikiPageWikiLink Johnson_&_Johnson.
- Golimumab wikiPageWikiLink Merck_&_Co..
- Golimumab wikiPageWikiLink Methotrexate.
- Golimumab wikiPageWikiLink Monoclonal_antibody.
- Golimumab wikiPageWikiLink Psoriatic_arthritis.
- Golimumab wikiPageWikiLink Randomized_controlled_trial.
- Golimumab wikiPageWikiLink Rheumatoid_arthritis.
- Golimumab wikiPageWikiLink Subcutaneous_injection.
- Golimumab wikiPageWikiLink TNF_inhibitor.
- Golimumab wikiPageWikiLink Tumor_necrosis_factor_alpha.
- Golimumab wikiPageWikiLink Ulcerative_colitis.
- Golimumab wikiPageWikiLinkText "''go''limumab".
- Golimumab wikiPageWikiLinkText "Golimumab".
- Golimumab wikiPageWikiLinkText "Simponi".
- Golimumab wikiPageWikiLinkText "golimumab".
- Golimumab wikiPageWikiLinkText "golimumab-Simponi".
- Golimumab atcPrefix "L04".
- Golimumab atcSuffix "AB06".
- Golimumab c "6530".
- Golimumab casNumber "476181".
- Golimumab chembl "1201833".
- Golimumab chemspiderid "none".
- Golimumab h "10068".
- Golimumab kegg "D04358".
- Golimumab legalUs "Rx-only".
- Golimumab licenceEu "Simponi".
- Golimumab licenceUs "Golimumab".
- Golimumab mabType "mab".
- Golimumab medlineplus "a610010".
- Golimumab molecularWeight "147".
- Golimumab n "1752".
- Golimumab o "2026".
- Golimumab routesOfAdministration Subcutaneous_injection.
- Golimumab s "44".
- Golimumab source "u".
- Golimumab target Tumor_necrosis_factor_alpha.
- Golimumab tradename "Simponi".
- Golimumab type "mab".
- Golimumab unii "91".
- Golimumab verifiedfields "changed".
- Golimumab verifiedrevid "458275071".
- Golimumab wikiPageUsesTemplate Template:Cascite.
- Golimumab wikiPageUsesTemplate Template:Chemspidercite.
- Golimumab wikiPageUsesTemplate Template:Drugbankcite.
- Golimumab wikiPageUsesTemplate Template:Drugbox.
- Golimumab wikiPageUsesTemplate Template:Drugs.com.
- Golimumab wikiPageUsesTemplate Template:Ebicite.
- Golimumab wikiPageUsesTemplate Template:Fdacite.
- Golimumab wikiPageUsesTemplate Template:Immunosuppressants.
- Golimumab wikiPageUsesTemplate Template:Keggcite.
- Golimumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Golimumab wikiPageUsesTemplate Template:Reflist.
- Golimumab subject Category:Janssen_Biotech.
- Golimumab subject Category:Johnson_&_Johnson.
- Golimumab subject Category:TNF_inhibitors.
- Golimumab hypernym Antibody.
- Golimumab type ChemicalSubstance.
- Golimumab type Company.
- Golimumab type Drug.
- Golimumab type Antibody.
- Golimumab type Brand.
- Golimumab type Chemical.
- Golimumab type Company.
- Golimumab type Drug.
- Golimumab type Inhibitor.
- Golimumab type Redirect.
- Golimumab type ChemicalObject.
- Golimumab type Thing.
- Golimumab type Q8386.
- Golimumab comment "Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.Golimumab was developed by Centocor and is approved in Canada and the United States as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.".
- Golimumab label "Golimumab".
- Golimumab sameAs Q413879.
- Golimumab sameAs غوليموماب.
- Golimumab sameAs Golimumab.
- Golimumab sameAs Golimumab.
- Golimumab sameAs Golimumab.
- Golimumab sameAs گولیموماب.
- Golimumab sameAs Golimumab.
- Golimumab sameAs Golimumab.
- Golimumab sameAs ゴリムマブ.
- Golimumab sameAs m.027yxww.
- Golimumab sameAs Golimumab.